Data News > Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Updates

Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Updates

By KlickAnalytics Data Insights  |   December 31, 2024 08:02PM ET

Key Points

- Investors who suffered losses in Cassava Sciences, Inc. (SAVA) urged to act before February 10, 2025
- Class action lawsuits filed against Cassava Sciences, Inc. by multiple law firms
- Defendants accused of violating federal securities laws between February 7, 2024, and November 24, 2024
- Shareholders advised to contact Levi & Korsinsky, Pomerantz Law Firm, or Bronstein, Gewirtz and Grossman, LLC for more information
- Cassava Sciences, Inc. investors can seek potential recovery under federal securities laws

Several law firms, including Levi & Korsinsky, Pomerantz Law Firm, and Bronstein, Gewirtz and Grossman, LLC, have filed class action lawsuits against Cassava Sciences, Inc. (SAVA) for alleged securities fraud. The lawsuits seek to recover damages on behalf of investors who purchased or acquired Cassava securities between February 7, 2024, and November 24, 2024, the Class Period.

Investors who suffered losses on their Cassava Sciences, Inc. investment during the specified period are advised to contact the law firms before the impending deadline on February 10, 2025. Joseph E. Levi, Esq., Danielle Peyton, and other representatives are available to provide information and discuss potential recoveries under the federal securities laws.

The lawsuits claim that Cassava Sciences, Inc. and certain officers violated federal securities laws during the Class Period. Shareholders who lost money on their investments in the company are urged to take action and explore their legal options. By contacting the mentioned law firms, investors can stay informed about the pending class action suit and how it may impact their rights.

With the lead plaintiff deadline approaching, Cassava Sciences, Inc. investors should be proactive in seeking guidance on how to proceed with the securities fraud class action lawsuit. The law firms handling the case are dedicated to assisting affected shareholders and providing necessary information for them to make informed decisions regarding their potential recovery.

In light of the ongoing developments surrounding the securities fraud class action lawsuit against Cassava Sciences, Inc., investors are strongly encouraged to reach out to Levi & Korsinsky, Pomerantz Law Firm, or Bronstein, Gewirtz and Grossman, LLC, to stay informed about the legal proceedings and protect their rights as shareholders in the company. By acting promptly, investors can ensure they are properly represented and have a chance of seeking potential recovery under the federal securities laws.

For more information:
  • Up/Down Rally
  • Price Distribution
  • Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality


  • Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.